Filters

Scott L Letendre, Igor Grant, Susan Morgello, David M Simpson, J Allen McCutchan, Justin C McArthur, Benjamin B Gelman, Ann C Collier, Christina M Marra, David B Clifford, Michael J Taylor, Anya Umlauf, Christine Fennema-Notestine, Albert M Anderson

Journal of neurovirology 2016;21(5):559-67

Free Full Text

Abstract

Does choice of combination antiretroviral therapy (cART) alter changes in cerebral function testing after 48 weeks in treatment-naive, HIV-1-infected individuals commencing cART? A randomized, controlled study.

Alan Winston, David A Cooper, Sean Emery, Simon D Taylor-Robinson, Kathy Petoumenos, Rebekah Puls, Stephen J Kerr, John M Gill, Patrick C K Li, Chris Duncombe

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2010;50(6):920-9

Free Full Text

Abstract

Nuclear-Mitochondrial interactions influence susceptibility to HIV-associated neurocognitive impairment.

Z Zhao, D C Samuels, P Jia, S Smieszek, J Barnholtz-Sloan, W S Bush, A Kallianpur, T Hulgan, D R Franklin, R Ellis, S Letendre, H Kaur

Mitochondrion 2019;46():247-255

Free Full Text

Abstract

Results: 1 – 15 / 47

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""AIDS Dementia Complex""[mesh_terms]

HIV/neuroAIDS biomarkers.

Role of trophic factors on neuroimmunity in neurodegenerative infectious diseases.

Human immunodeficiency virus (HIV) proteins in neuropathogenesis of HIV dementia.

Getting into the brain: Potential of nanotechnology in the management of NeuroAIDS.

Implications of efavirenz for neuropsychiatry: a review.

Neuroprotection in HIV-positive drug users: implications for antioxidant therapy.

Could cholinesterase inhibitors and memantine alleviate HIV dementia?

Chemokine receptor utilization and macrophage signaling by human immunodeficiency virus type 1 gp120: Implications for neuropathogenesis.

Pathogenesis of HIV-associated cardiomyopathy.

Cognitive function in HIV-1-infected drug users.

Selegiline and oxidative stress in HIV-associated cognitive impairment.

Promoting successful cognitive aging in adults with HIV: strategies for intervention.

CSF biomarkers of monocyte activation and chemotaxis correlate with magnetic resonance spectroscopy metabolites during chronic HIV disease.

Does choice of combination antiretroviral therapy (cART) alter changes in cerebral function testing after 48 weeks in treatment-naive, HIV-1-infected individuals commencing cART? A randomized, controlled study.

Nuclear-Mitochondrial interactions influence susceptibility to HIV-associated neurocognitive impairment.

Results for
""AIDS Dementia Complex""[mesh_terms]